Garheng Kong
CIK 1435183 · last filed 2026-06-05
Garheng Kong is a corporate insider who has filed 77 SEC Form 4 insider transactions across 10 companies since 2012. The most recent filing, for XERS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $57.5M across reported positions. 26 SEC filings were submitted jointly with LABORATORY CORP OF AMERICA HOLDINGS.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CSTL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | Director | 238,337 | $16.61 | $3.96M | $0 | 7 | 2026-06-05 |
| LH | Director | 13,739 | $369.85 | $5.08M | $0 | 24 | 2026-02-13 |
| Venus Concept Inc. (VERO) Delisted | Director | 41,186 | $0.31 | $12.8K | $2.00M | 8 | 2023-03-28 |
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | — | $5.54 | — | $0 | 12 | 2023-01-06 |
| Strongbridge Biopharma plc (SBBP) Delisted | Director | 0 | $2.00 | $0 | $0 | 8 | 2021-10-06 |
| CSTL | 10%+ Owner | 1,433,577 | $33.79 | $48.44M | -$8.62M | 1 | 2020-05-14 |
| AVEDRO INC (AVDR) Delisted | Director | 0 | $24.25 | $0 | $2.00M | 3 | 2019-11-26 |
| Venus Concept Inc. (HAIR) Delisted | Director | 266,375 | — | — | $0 | 1 | 2019-11-07 |
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Director | — | — | — | $0 | 1 | 2018-06-14 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 2,830 | — | — | $49.3K | 7 | 2017-01-05 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| VERO | Held by HealthQuest Partners II, L.P. | 41,186 | 100.0% | 2021-12-17 |
| Total | 41,186 | |||
| No longer reported | ||||
| HealthQuest Partners II, L.P. By Partnership |
31,489 | — | last 2020-06-18 | |
| AVDR | HealthQuest Partners II, L.P. See footnote |
0 | — | 2019-11-26 |
| Total | 0 | |||
| HAIR | HealthQuest Partners II, L.P. By Partnership |
266,375 | 100.0% | 2019-11-07 |
| Total | 266,375 | |||
Recent Filings
77 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | XERS | Grant (A) | +24,193 | $0 | EDGAR |
| 2026-02-13 | LH | Exer (M) | +897 | $0 | EDGAR |
| 2026-02-12 | LH | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | XERS | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-02-13 | LH | Grant (A) | — | $0 | EDGAR |
| 2025-02-10 | LH | Exer (M) | +944 | $0 | EDGAR |
| 2024-06-05 | XERS | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-04-01 | XERS | Other (J) | +6,474 | $0 | EDGAR |
| 2024-02-08 | LH | Mixed | +947 | $0 | EDGAR |
| 2023-06-07 | XERS | Grant (A) | +42,500 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).